Kailera Therapeutics, Inc. (KLRA)
21.47
+0.39
(+1.85%)
USD |
NASDAQ |
May 22, 10:12
Kailera Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | 0.00 |
| Oruka Therapeutics, Inc. | -14.44M |
| MapLight Therapeutics, Inc. | 67.01M |
| Veracyte, Inc. | -127.96M |
| Insight Molecular Diagnostics, Inc. | -0.613M |